Fact CheckerSign in

NCT06374706Completed

Effects of Rehabilitation Robots-Morning Walk in Individuals With Hemiparesis

Effects of End-Effector Type Rehabilitation Robots-Morning Walk on Symmetrical Walking Patterns in Individuals With Hemiparesis

Source: ClinicalTrials.gov · Last updated 10 Apr 2025

Brief summary (registry, in English)

In this study, our objective is to explore and evaluate interventions to improve the process of recovery following a stroke. The main focus is on enhancing symmetrical walking patterns in adults who have experienced neurological deficits due to a stroke. The primary tool will be an end-effector type rehabilitation robot, the Morning Walk®. This robot has been specifically designed to assist in enhancing symmetrical walking patterns for individuals recovering from a stroke Morning Walk® has received approval from the FDA, meaning it meets stringent safety and efficacy standards.

Status (registry)
Completed
Study type
Interventional
Enrollment
37 (actual)
First submitted
24 Mar 2024
Start date
30 May 2024
Primary completion date
18 Feb 2025
Lead sponsor
The University of Texas Medical Branch, Galveston
Diseases
Stroke
NCT number
NCT06374706

What you commit to

  • Study type: Interventional
  • Participants enrolled: 37
  • From 30 May 2024 to the primary completion date, 18 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Stroke secondary to subarachnoid hemorrhage or posterior circulation stroke.
  • Poorly controlled diabetes, exemplified by conditions such as foot ulceration.
  • Progressive neurological diseases.
  • Congestive cardiac failure.
  • Unstable angina.
  • Peripheral vascular disease.
  • Neuropsychiatric disorders, including dementia, cognitive deficits, and severe depression.

Other

  • Life expectancy of less than one year.
  • Comatose state.
  • Inability to follow 3-step commands.
  • Amputation.
  • Blindness.
  • Comprehensive aphasia.
  • Medical instability.
  • Significant musculoskeletal problems.

Who the study is looking for

  • For this study, twenty volunteers fulfilling the inclusion criteria from participating physical therapy facilities and the local community will be recruited. The criteria for participants with a history of stroke include: Age 20 or older.
  • Experienced a unilateral first stroke, either ischemic or hemorrhagic, in the carotid artery distribution.
  • Diagnosed with stroke at least one month prior to participating in the study.
  • Free from major post-stroke complications, such as recurrent stroke, hip fracture, or myocardial infarction.
  • Residing within the community.
  • Capable of ambulating 10 meters with or without the use of assistive devices.

Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas Medical Branch
Coordinator of this site? Confirm its status
GalvestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.